Stuart Jackson

Stuart Jackson is an experienced pharmaceutical executive with a strong background in oncology and business strategy. As Chief Operating Officer at AstraZeneca since February 2021, Stuart oversees oncology research and development initiatives. Prior to this role, Stuart served at Roche from 2010 to 2021, holding various leadership positions including Global Head of Business Strategy and Operations for Oncology. Stuart's earlier experience includes roles as Senior Development Excellence Leader, International Business Leader in Haematology, Strategy Implementation Manager, and Head of Business & Market Development at Roche. Stuart holds a Bachelor of Science degree in Aquatic Biology and Biochemistry from the University of Wales.